Ryan J. Selhorn - 05 Feb 2025 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role: Chief Financial Officer
Signature: /s/ Ryan J. Selhorn
Issuer symbol: AYTU
Transactions as of: 05 Feb 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Mar 2025, 19:22:47 UTC
Previous filing: 13 Nov 2024
Next filing: 07 Oct 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AYTU	Common Shares	Options Exercise		+105	+0.66%		16,000	05 Feb 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AYTU	Restricted Stock Units	Options Exercise	$0	-105	-100%	$0.000000	0	05 Feb 2025	Common Shares	105		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units (RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted February 5, 2022, vesting quarterly beginning February 5, 2023, and ending February 5, 2025.